Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 28, 1998

View Archived Issues

Company Profile: CpG ImmunoPharmaceuticals

Gliadel Wafer approved in Canada and France

Dura and Bristol-Myers Squibb sign exclusive license agreement

Shaman achieves favorable phase III results with diarrhea treatment in AIDS patients

Collaborative work by Janssen and Neurocrine Biosciences related to CRF antagonists

New 5-HT4 and/or H3 receptor ligands designed at Synthelabo

Agents for epilepsy, stroke and brain, spinal cord trauma in development at Novartis

Guilford patents NAALADase inhibitors for glutamate abnormalities, prostate conditions

Revolutionary drugs for Alzheimer's ready for human testing described by Nymox

In vivo safety and efficacy of photodynamic therapy evaluated by Theratechnologies in CML patients

Improvement in ischemia-reperfusion lung injury by treatment with FR-167653

Humanized anti-IL-6 antibody shows good efficacy and safety as rheumatoid arthritis Rx

Combination of PGE1 + rolipram or pentoxifylline shows potential for RA

Aged garlic extract: in vitro and in vivo antiallergic effects

First convincing data for extended therapeutic gene expression by human stem cells

Amgen's rights to NESP affirmed by arbitrator panel

Four-year drug target collaboration signed by PPD and RPR

Isis obtains antisense cancer rights from Genzyme Molecular Oncology

Astra and Schering-Plough sign new marketing agreements for several drugs

Pharmacokinetics of YJA-20379-8 not affected by water deprivation in rats

Hyseq presents gene product with potential application to vaccine development

U.S. patent issued for primate embryonic stem cells; Geron holds license

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...